Midwest Institute for Clinical Research

Indianapolis, Indiana 46260

0 studies enrolling now · 40 studies all time

What they study most

Atherosclerotic Cardiovascular Disease, Blood Pressure, High, Chronic Migraine, Diabetes, Diabetes Mellitus, Type 2, Dyslipidemias, Essential Hypertension, Familial Hypercholesterolemia, High Cholesterol, Hypercholesteremia, Hypercholesterolemia, Hyperlipidemia

Studies at this site

• A Cross-sectional Study of Lipoprotein(a) Levels in Patients With Documented History of Atherosclerotic Cardiovascular Disease (ASCVD) — Completed
• Randomized Study to Evaluate the Effect of Obicetrapib on Top of Maximum Tolerated Lipid-Modifying Therapies — Completed
• A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight — Completed
• Randomized Study of Obicetrapib as an Adjunct to Statin Therapy — Completed
• Study to Evaluate the Effect of Obicetrapib in Combination With Ezetimibe as an Adjunct to HIS Therapy — Completed
• A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight for the Maintenance of Weight Loss — Completed
• Efficacy and Safety of ALT-801 in the Treatment of Obesity — Completed
• A Research Study to Show the Effect of Aprocitentan in the Treatment of Difficult to Control (Resistant) High Blood Pressure (Hypertension) and Find Out More About Its Safety — Completed
• A Study to Assess the Safety, Tolerability and Efficacy of IONIS-AGT-LRx — Completed
• A Study to Assess the Safety, Tolerability and Efficacy of IONIS-AGT-LRx, an Antisense Inhibitor Administered Subcutaneously to Hypertensive Participants With Controlled Blood Pressure — Completed
• Study to Evaluate the Efficacy and Safety of K-877 in Adult Patients With Fasting High Triglyceride Levels and Normal Renal Function — Completed
• Dose-finding Study With ACT-132577 (Aprocitentan) in Participants With Essential Hypertension — Completed
• Study to Evaluate the Efficacy and Safety of K-877 in Adult Patients With Fasting High Triglyceride Levels and Mild or Moderate Renal Impairment — Completed
• Evaluation of Galcanezumab in the Prevention of Chronic Migraine — Completed
• A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis — Completed
• Phase 2a, Dose-ranging Study With PF-05221304 in Nonalcoholic Fatty Liver Disease (NAFLD) — Completed
• A Study To Assess Pharmacodynamics, Safety And Tolerability Of PF-05221304 And PF-06865571 Co-Administered For 6 Weeks In Adults With Non-Alcoholic Fatty Liver Disease. — Completed
• A Study of LY2623091 in Participants With High Blood Pressure — Completed
• A 12-Week, Phase 2 Study of Gemcabene in Hypercholesterolemia Patients on Stable Moderate and High-Intensity Statins — Completed
• Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study — Completed
• A Study of the Efficacy and Safety of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes — Completed
• A Study of Evacetrapib (LY2484595) in Participants With High Cholesterol — Stopped early
• Trial to Evaluate the Effect of ALN-PCSSC Treatment on Low Density Lipoprotein Cholesterol (LDL-C) — Completed
• Study to Evaluate Efficacy and Safety of LIB003 in Patients on Lipid-Lowering Therapy Needing Additional LDL-C Reduction — Completed
• Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events — Completed
• A Study of LY2409021 on Blood Pressure and Pulse Rate in Participants With Type 2 Diabetes Mellitus — Completed
• AEGR-733 and Atorvastatin 20 mg vs. Monotherapy in Moderate Hypercholesterolemia — Completed
• Efficacy, Safety, Tolerability And Actual Use Study Of Bococizumab And An Autoinjector (Pre-Filled Pen) In Subjects With Hyperlipidemia Or Dyslipidemia — Completed
• Monthly And Twice Monthly Subcutaneous Dosing Of PF-04950615 (RN316) In Hypercholesterolemic Subjects On A Statin — Completed
• A 12-week Study To Evaluate PF-06291874 Once a Day in Adults With T2DM Inadequately Controlled On Metformin — Completed
• Randomized Clinical Trial Of Bococizumab (PF-04950615; RN316) In Subjects With Hyperlipidemia Or Mixed Dyslipidemia At Risk Of Cardiovascular Events — Completed
• Evaluation of ARI-3037MO, to Suppress LDL Cholesterol in Patients With Dyslipidemia — Status unconfirmed
• Performance Evaluation of an Investigational Blood Glucose Monitoring System — Completed
• The Effect of Betahistine on Body Weight in Obese Subjects — Completed
• Ramipril and Hydrochlorothiazide Alone and in Combination for the Treatment of Essential Hypertension — Completed
• Treatment of High Blood Pressure Using Olmesartan With Hydrochlorothiazide Compared to an ACE Inhibitor With a Calcium Channel Blocker — Completed
• A Study To Evaluate The Dose-Related Efficacy and Safety of PS433540 in Subjects With Hypertension — Completed
• Study of MB07811 in Subjects With Hypercholesterolemia — Withdrawn before enrolling
• Diazoxide Choline in Hypertriglyceridemia — Completed
• Study on the Safety and Effects on Lipids of FM-VP4 in Subjects With Primary Hypercholesterolemia — Completed